CLEARBRIDGE Health 1H3 : 1H3 0% on Wednesday said its second batch of Sinopharm Covid-19 vaccines have arrived in Singapore.

The vaccines will be available at Medic Surgical & Laser Clinic, operated by the group's subsidiary, the integrated healthcare group said in a bourse filing.

The group's first batch of Sinopharm vaccines had arrived in Singapore on Aug 28 and were fully allocated in early September.

Clearbridge Health said it has also facilitated other healthcare institutions in Singapore to have access to the Sinopharm vaccine. This includes Royal Healthcare Specialists Centre, which will be taking part of this second batch of vaccine shipment under the special access route approved by the Health Sciences Authority.

The group said these healthcare institutions have certain reporting obligations to its manufacturer China National Biotec Group (CNBG), such as reporting of adverse events after inoculation.

Clearbridge Health's unit, Clearbridge Medical Group, had earlier entered into a contract to purchase the Sinopharm Covid-19 vaccine directly from its manufacturer, which includes CNBG and Beijing Institute of Biological Product.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Sign UpVIEW ALL

The Sinopharm Covid-19 vaccine has been authorised for conditional and emergency use in several countries, and is listed by the World Health Organization for emergency use.

The group said it aims to procure and supply the Sinopharm vaccine in Singapore and other countries in the region.

Shares of Catalist-listed Clearbridge Health closed at 13.2 Singapore cents on Tuesday, up 2.6 cents or 24.5 per cent.

READ MORE

• Hot stock: Clearbridge Health up 10.5%; unit to supply Sinopharm Covid-19 vaccine for use in Singapore

• Lawsuit against two Clearbridge units dismissed over jurisdiction issue